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benefits. However, little is known regarding the ability of the polyphenols or their
metabolites from polyphenolͲrich products to cross the bloodͲbrainͲbarrier, and be




disease on polyphenol bioavailability from a ‘Standardized Grape Polyphenol’ (grape
seedextract,Concordgrape juiceandresveratrol).Additionally,thisthesiswillprovide

























































































































Flavones – apigenin, luteolin
Isoflavones – daizein, genistein
Flavanones – naringenin, hesperetin
Flavonols – quercetin, kaempferol, myricetin
Anthocyanidins – malvidin, petunidin, peonidin, 
delphinidin, cyanidin
Flavn-3-ols – catechin, epicatechin
Phenolic acids – hydroxybenzoic acids and hydroxycinnamic acids
Lignans



































































































































































































Food Source (+)-Catechin (-)-Epicatechin
chocolate bar, dark 11.99 41.5
chocolate bar, milk 2.9 10.45
Apple, with skin 0.95 8.14
Apple, no skin 0.86 6.23
Grape juice, canned or bottled 0.19 0
Grape, red NA 1.95
Grape, black 8.94 8.64
Bilberry, raw NA NA
Onion, cooked NA NA
Onoin, raw NA NA
Tea, black, brewed 1.52 2.33
Tea, green, brewed 2.73 8.47















Flavonols R1 R2 R3 R4
Quercetin -OH -H -H -H
Kaempferol -H -H -H -H
Myricetin -OH -OH -H -H
Derivatives
Rutin -OH -H -OH Rutinose










































Food Source Quercetin aglycon content (mg/100g)
Capers, canned 180.77
Apple, with skin 4.42
Apple, no skin 1.5






Tea, black, brewed 2.07

















Cyanidin (Cy) -OH -H
Malvidin (Mv) -OCH3 -OCH3
Delphinidin (Dp) -OH -OH
Peonidin (Pn) -OCH3 -H
























Food Source Cy Dp Mv Pn Pt




Bilberry, raw 15.02 29.54 49.21 7.05 11.73





























































































































































































































































































































































































































































































































human redwine(120mL) 35mgcatechin acute oral Total(methylated,
unmethylatedandsulfated)
371(0Ͳ8h) 78 1.5 emzymatic
Haradaetal.













human redwine(120mL) 35mgcatechin acute oral Total(methylated,
unmethylatedandsulfated)
382(0Ͳ8h) 75 1.5 emzymatic
DaSilvaetal.






























Quercetin Model Formulation Dose Duration Treatment
Target
















human applecider 1.6mgquercetineq. acute oral 3'Ͳmethylquercetinn na(0Ͳ24h) 140 na enzymatic
Graefeetal.
(2001)
human onions 100mgquercetineq. acute oral quercetin
(freeandconjugated)
32.1(0Ͳ24h) 7.6 0.68 enzymatic
Graefeetal.
(2001)
human quercetin4'Ͳglucoside 100mgquercetineq. acute oral quercetin
(freeandconjugated)
27.8(0Ͳ24h) 7 0.7 enzymatic
Graefeetal.
(2001)
human buckweattea 200mgquercetineq. acute oral quercetin
(freeandconjugated)
12.6(0Ͳ24h) 2.1 4.3 enzymatic
Graefeetal.
(2001)
human purerutin 200mgquercetineq. acute oral quercetin
(freeandconjugated)
8.3(0Ͳ24h) 1.1 7 enzymatic
Hollmanetal.
(1997)
human apple 107mgquercetineq. acute oral quercetin
(freeandconjugated)
3500(0Ͳ36h) 300 2.5 enzymatic
Hollmanetal.
(1997)
human onions 68mgquercetineq. acute oral quercetin
(freeandconjugated)
7700(0Ͳ36h) 740 0.7 enzymatic
Hollmanetal.
(1997)
human purerutin 100mgquercetineq. acute oral quercetin
(freeandconjugated)
3.3(0Ͳ36h) 0.3 9.3 enzymatic
Resveratrol Model Formulation Dose Duration Treatment
Target























































































Anthocyanidins Model Formulation Dose Duration Treatment
Target









rabbit blackcurrantjuice 117mgtotalantho/kgbw acute gavage totalac 13.4(0Ͳ4) 2 0.5 SPE
Rechneretal.
(2002)















































human elderberryjuice(sprayͲdried) 720mgtotalantho/kgbw acute oral totalac na 97 1.1Ͳ1.2 SPE
Mazzaetal.
(2001)
human blueberry(freezeͲdried) 1.2gtotalantho acute oral totalac 41.4(0Ͳ4) 13.09 4 SPE
Bubetal.
(2001)
human redwine(500mL) 68mgMvͲ3Ͳglucoside acute oral MvͲ3Ͳglucoside 288 1.38 0.83 enzymatic
Bubetal.
(2001)
human redgrapejuice 117mgMvͲ3Ͳglucoside acute oral MvͲ3Ͳglucoside 662 3 1.5 enzymatic
Miyazawaetal.
(1997)
human redfruitextract(1.6g) 2.7mgCyͲ3Ͳglucoside/kgbw acute oral CyͲglucoside na 29 1 SPE
Miyazawaetal.
(1997)




































































































(2002) Wistarrats ECaglycon 100mg/kgbw 1d gavage perfusion immediately
ECglucur
3'MeͲECglucur <LOQ NA enzymatic
Suganumaetal.
(1998)
CDͲ1mice (3H)EGCG 0.05% actue gavage NA NA (3H)EGCG 17.3X103 dpm/g NA
NakagawaandMiyazawa
(1997) SDrats EGCG 500mg/kgbw acute gavage perfusion 1h EGCG 0.5 nmol/g liquid













































11wks diet NA NA Qaglycon 0.06 nmol/g enzymatic
deBoeretal.
(2005)
pig Qaglycon 500mg/kgbw 3d diet NA NA Qaglycon 0.22 nmol/g enzymatic
Mullenetal.
(2002) wattHoodedLister [2Ͳ14C]QͲ4'Ͳglucoside 58.5x10
5dpm acute withfeed perfusion 1h [2Ͳ14C]QͲ4'Ͳglucoside 0 03/g/mlfresh NA
















(2012) SDrats Polygonaceae 4g/kgbw 2x/d,7does gavage perfusion 30min
Resglucur
Ressulafte ND NA enzymatic
Juanetal.
















1.85Mba(3H)transͲres ? gavage acute 2or18h (3H)transͲres
2h:0.03%oforaldose
18h:0.01%oforaldose NA NA



















SDrats blueberry 8%indiet 4or8wks diet perfusion NA nativeforms ND NA SPE
MilburyandKalt











SDrats pelargonidin 50mg/kgbw acute gavage perfusion 2h pelargonidinaglycon 0.16 nmol/g SPE
AndresͲLacuevaetal.









Wistarrat blackberry 15g/kgbw 15d diet perfusion 3h cyͲ3Ͳglc 0.21+0.05 nmol/g SPE
Passamontietal.
































































































































































































































































































































































Flavonols FlavanͲ3Ͳols Anthocyanins Stilbenoids

































































































































































































0 1 2 3 4 5 6 7 8
Diet Compound AUC(nmol/LͲh) Cmax (nmol/L) Tmax (h)
CNTL CͲ5Ͳglucur 7888.9Ʋ 186.5 2458.4Ʋ 263.4 1.7Ʋ 0.3
HF 9192.9Ʋ 747.5 3660.6Ʋ 783.4 2.0Ʋ 0.0
CNTL ECͲ5Ͳglucur 9122.2 Ʋ 303.9 2791.4 Ʋ 188.7 1.7Ʋ 0.3
HF 14654.0Ʋ 1571.7* 5058.4Ʋ 588.6* 2.0Ʋ 0.0
CNTL 3’OMeCͲ5Ͳglucur 12566.0Ʋ 557.4 2820.5Ʋ 67.8 2.0Ʋ 0.0
HF 12545.9Ʋ 772.0 2964.8Ʋ 54.1 2.0Ʋ 0.0
CNTL 3’OMeECͲ5Ͳglucur 18463.3Ʋ 472.7 4203.6Ʋ 128.5 2.0Ʋ 0.0
























































Diet Compound AUC(nmol/LͲh) Cmax (nmol/L) Tmax (h)
CNTL MeQͲQͲglucur 410.1Ʋ 43.9 78.8Ʋ 8.8 0.5Ʋ 0.2
HF 370.8Ʋ 14.8 95.7Ʋ 9.6 0.6Ʋ 0.2
CNTL QͲ3Ͳglucur 385.4Ʋ 72.2 118.6Ʋ 41.5 0.3Ʋ 0.0












Diet Compound AUC(µmol/LͲh) Cmax (ʅmol/L) Tmax (h)
CNTL ResͲglucur 456.4Ʋ 76.0 78.5Ʋ 3.2 1.0Ʋ 0.5














































































Diet Compound AUC(nmol/LͲh) Cmax (nmol/L) Tmax (h)
CNTL MvͲglucoside 15.9Ʋ 0.4 4.2Ʋ 0.4 0.3Ʋ 0.0
HF 17.3Ʋ 0.5 3.7Ʋ 0.1 0.3Ʋ 0.0
CNTL PtͲglucoside 19.8Ʋ 4.1 3.1Ʋ 0.1 0.3Ʋ 0.0
HF 16.4Ʋ 0.3 3.3Ʋ 0.2 0.3Ʋ 0.0
CNTL DpͲglucoside 16.8Ʋ 0.2 4.2Ʋ 0.1 0.30.0
HF 16.9Ʋ 0.3 4.0Ʋ 0.3 0.3Ʋ 0.0
CNTL PnͲglucoside 17.4Ʋ 0.5 3.9Ʋ 0.2 0.3Ʋ 0.0
HF 18.3Ʋ 0.8 3.6Ʋ 0.3 0.3Ʋ 0.0
CNTL CyͲglucoside 10.3Ʋ 1.5 9.6Ʋ 0.9 0.3Ʋ 0.0

































































































































































































































































































































SGP(mg/g) Dose(mg) Cmax (µmol/L) AUC(µmol/L*h) Brain(pmol/g) Cmax (ʅM/mg) AUC(µM*h/mg) Brain(nM/mg)
CͲ5Ͳglucur 5.600 2.776 2.460 7.890 485.790 0.886 2.842 174.966
ECͲ5Ͳglucur 6.490 3.218 2.790 9.120 637.220 0.867 2.834 198.033
3'OMeCͲ5Ͳglucur 5.600 2.776 2.820 12.570 664.290 1.016 4.527 239.256
3'OMeECͲ5Ͳglucur 6.490 3.218 4.200 18.460 853.830 1.305 5.737 265.351
QͲ3Ͳglucur 0.090 0.045 0.119 0.385 2.410 2.658 8.636 54.009
MeOͲQͲglucur 0.090 0.045 0.079 0.410 0.690 1.766 9.191 15.463
MvͲglucoside 0.014 0.007 0.004 0.016 0.170 0.602 2.294 24.491
PtͲglucoside 0.015 0.007 0.003 0.020 0.100 0.418 2.668 13.446
DpͲglucoside 0.030 0.015 0.004 0.017 0.070 0.282 1.129 4.706
PnͲglucoside 0.010 0.005 0.004 0.017 0.120 0.785 3.507 24.203
CyͲglucoside 0.023 0.011 0.010 0.010 0.070 0.843 0.901 6.139








































































































































































































TotalPolyphenolic Content GrapeJuice GSE Resveratrol







































































































































































































































QMetabolite R1 R2 R3
Q OH OH OH
































































































































































































































































CͲ5Ͳglucur ZDFͲSGP 76.3Ʋ 16.7 18.5Ʋ 3.6 2.3Ʋ 0.5
LNͲSGP 93.4Ʋ 11.0 35.9Ʋ 4.7* 1.5Ʋ 0.2
ECͲ5Ͳglucur ZDFͲSGP 59.7Ʋ 13.5 15.5Ʋ 2.8 2.1Ʋ 0.4
LNͲSGP 81.2Ʋ 11.3 31.3Ʋ 4.3* 1.6Ʋ 0.2
3’ͲOMeCͲ5Ͳglucur ZDFͲSGP 25.1Ʋ 13.5 5.4Ʋ 2.9 1.8Ʋ 0.2
LNͲSGP 108.1Ʋ 6.7* 24.8Ʋ 1.6* 1.8Ʋ 0.2
3’ͲOMeECͲ5Ͳglucur ZDFͲSGP 23.0Ʋ 12.4 4.9Ʋ 2.6 2.0Ʋ 0.0
















































































Treatment AUC0Ͳ8h(nmol/L*h) Cmax (nmol/L) Tmax (h)
QͲ3Ͳglucur ZDFͲSGP 28.6Ʋ 2.7 8.2Ʋ 1.4 0.6Ʋ 0.1
LNͲSGP 50.7Ʋ 7.3* 15.4Ʋ 2.1* 1.3Ʋ 0.4
MeOͲQͲglucur ZDFͲSGP 71.9Ʋ 3.2 14.3Ʋ 0.6 2.5Ʋ 0.8



























Treatment AUC0Ͳ8h(µmol/L*h) Cmax (µmol/L) Tmax (h)
ResͲ3Ͳglucur ZDFͲSGP 180.8Ʋ 20.5 34.4Ʋ 3.5 2.6Ʋ 0.8


























































































Treatment AUC0Ͳ8h(nmol/L*h) Cmax (nmol/L) Tmax (h)
MvͲ3Ͳglucoside ZDFͲSGP 2.3Ʋ 0.5 0.9Ʋ 0.3 0.8Ʋ 0.6
LNͲSGP 2.7Ʋ 0.5 1.0Ʋ 0.2 0.3Ʋ 0.0
PtͲglucoside ZDFͲSGP 1.6Ʋ 0.1 0.6Ʋ 0.1 0.8Ʋ 0.6
LNͲSGP 1.9Ʋ 0.3 0.7Ʋ 0.1 0.3Ʋ 0.0
DpͲglucoside ZDFͲSGP 2.1Ʋ 0.4 1.3Ʋ 0.5 0.8Ʋ 0.3
LNͲSGP 2.6Ʋ 0.3 1.7Ʋ 0.2 0.8Ʋ 0.3
PnͲglucoside ZDFͲSGP 2.4Ʋ 0.6 0.8Ʋ 0.3 0.3Ʋ 0.0
LNͲSGP 2.8Ʋ 0.6 1.0Ʋ 0.2 0.3Ʋ 0.0
CyͲ3Ͳglucoside ZDFͲSGP 1.9Ʋ 0.5 1.2Ʋ 0.5 0.8Ʋ 0.6






















































































Normalized by Dose Normalized by Dose












C-5-glucur 12.926 33.625 18.414 6.678 27.474 6.410 
EC-5-glucur 9.737 25.235 13.431 4.820 18.553 5.274 
3'OMeC-5-glucur 8.914 38.931 25.326 1.934 9.037 10.317 
3'OMeEC-5-glucur 7.477 34.266 15.987 1.523 7.132 6.709 
Q-3-glucur 0.345 1.137 8.875 0.183 0.642 3.877 
MeO-Q-glucur 0.622 2.757 5.827 0.320 1.137 2.913 
Mv-glucoside 0.150 0.383 0.000 0.130 0.333 0.000 
Pt-glucoside 0.100 0.255 0.000 0.083 0.214 0.000 
Dp-glucoside 0.116 0.173 0.000 0.085 0.143 0.000 
Pn-glucoside 0.196 0.555 0.000 0.163 0.480 0.000 
Cy-glucoside 0.132 0.196 0.000 0.103 0.167 0.000 




























































































































































































































































































































































































































































































































































,GHQWLILFDWLRQ 0507UDQVLWLRQ (6, 3RODULW\
(&JOXFXU !  1HJDWLYH
ಬ20H(&JOXFXU ! 1HJDWLYH
4JOXFXU !  3RVLWLYH
0H24JOXFXU ! 3RVLWLYH
0YJOXFRVLGHJDODFWRVLGH ! 3RVLWLYH









































































































































$QDO\WH 5HIHUHQFH5DQJH 7UHDWPHQW $YHUDJH 6(0 &RPSDUHGWRUHIUDQJH
7RWDO%LOOLUXELQ  &17/  




$VSDUWDWH$PLQRWUDQVIHUDVH  &17/  




$ONDOLQH3KRVSKDWDVH  &17/  




ˠ*OXWDP\O7UDQVIHUDVH  &17/  
**7 ,8/ +LJKDSSOH*6(   +LJK
/RZDSSOH*6(   +LJK
+LJK%LOEHUU\   +LJK














































































































































































































































Treatment AUC0-1440min (ȝmol/L*min) Cmax (ȝmol/L) Tmax (min)
C-5-glucur CNTL ND ND ND
High apple/GSE 27051.8 Ʋ 4883.5* 165.8 Ʋ 27.8* 90.0 Ʋ 7.7
Low apple/GSE 8273.5 Ʋ 987.7 50.8 Ʋ 8.3 85.0 Ʋ 12.0
EC-5-glucur CNTL ND ND ND
High apple/GSE 25282.0 Ʋ 3950.5* 158.3 Ʋ 24.4* 90.0 Ʋ 7.8
Low apple/GSE 7887.5 Ʋ 985.8 47.1 Ʋ 7.9 95.0 Ʋ 12.0
3’-OMeC-5-glucur CNTL ND ND ND
High apple/GSE 9662.8 Ʋ 1128.4* 35.4 Ʋ 3.2* 135.0 Ʋ 21.6
Low apple/GSE 399.2 Ʋ 46.5 1.5 Ʋ 0.1 120.0 Ʋ 13.4
3’-OMeEC-5-glucur CNTL ND ND ND
High apple/GSE 3609.2 Ʋ 471.1* 13.4 Ʋ 1.4* 145.0 Ʋ 16.3




























































7UHDWPHQW $8&PLQQPRO/PLQ &PD[ QPRO/ 7PD[ PLQ
4JOXFXU &17/ 1' 1' 1'
+LJKDSSOH*6( s  s  s 
/RZDSSOH*6( s  s  s 
0H24JOXFXU &17/ 1' 1' 1'
+LJKDSSOH*6( s  s  s 
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Treatment AUC0-1440min (pmol/L*min) Cmax (pmol/L) Tmax (min)
Mv-galactoside CNTL ND ND ND
High Bilberry 1700.3 Ʋ 925.4* 17.2 Ʋ 9.1* 58.0 Ʋ 13.0
Low Bilberry 9.3 Ʋ 8.0 0.2 Ʋ 0.2 NA
Pt-galactoside CNTL ND ND ND
High Bilberry 1325.6 Ʋ 816.6 12.7 Ʋ 3.9* 83.0 Ʋ 35.0
Low Bilberry 59.7  Ʋ 49.2 1.0 Ʋ 0.6 NA
Dp-galactoside CNTL ND ND ND
High Bilberry 4747.6 Ʋ 1420.6* 32.0 Ʋ 5.8* 99.0 Ʋ 33.0
Low Bilberry 931.6 Ʋ 484.9 12.5 Ʋ 4.2 65.0 Ʋ 17.0
Pn-galactoside CNTL ND ND ND
High Bilberry 3782.5 Ʋ 1123.8^ 23.3 Ʋ 3.8* 57.0 Ʋ 15.0
Low Bilberry 1187.8 Ʋ 504.3 9.9 Ʋ 2.9 87.0 Ʋ 18.0
Cy-galactoside CNTL ND ND ND
High Bilberry 22170.1 Ʋ 4437.9* 121.1 Ʋ 18.9* 52.0 Ʋ 15.0*
Low Bilberry 7153.2 Ʋ 2997.3 41.2 Ʋ 11.7 115.0 Ʋ 16.0
Mv-glucoside CNTL ND ND ND
High Bilberry 4597.4 Ʋ 1767.9^ 60.6 Ʋ 26.7^ 44.0 Ʋ 7.0
Low Bilberry 58.6 Ʋ 37.1 0.9 Ʋ 0.6 40.0 Ʋ 12.0
Pt-glucoside CNTL ND ND ND
High Bilberry 4251.3 Ʋ 1351.2* 39.3 Ʋ 12.6* 52.0 Ʋ 15.0
Low Bilberry 376.4 Ʋ 181.9 4.8 Ʋ 1.6 85.0 Ʋ 29.0
Dp-glucoside CNTL ND ND ND
High Bilberry 7905.5 Ʋ 2527.0^ 57.3 Ʋ 13.2* 62.0 Ʋ 19.0
Low Bilberry 1697.0 Ʋ 696.4 18.1 Ʋ 3.0 79.0 Ʋ 18.0
Pn-glucoside CNTL ND ND ND
High Bilberry 12553.8 Ʋ 3586.5* 93.27 Ʋ 18.5* 44.0 Ʋ 8.0
Low Bilberry 3044.2 Ʋ 1385.4 23.00 Ʋ 6.3 82.0 Ʋ 17.0
Cy-glucoside CNTL ND ND ND
High Bilberry 35391.3 Ʋ 7847.4* 223.5 Ʋ 36.8* 40.0 Ʋ 9.0





















































1Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am
Ce StCoHiHy Am Ce StCoHiHy AmCe StCoHiHy Am Ce StCoHiHy Am






























































































































1Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am
LowBilberry HighBilberry LowBilberry HighBilberry
Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am

































































1Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am
LowBilberry HighBilberry LowBilberry HighBilberry
Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am Ce StCoHiHy Am

























































































































































Ce St CoHiHy AmCe StCoHi Hy Am

























































1 2 3 4 5 6
PtͲgalactoside PtͲglucoside
MvͲgalactoside MvͲglucoside





ND ND ND ND ND ND
ND ND NDND ND ND
ND ND ND ND ND


















































ND ND NDND ND ND NDND NDND
ND ND ND NDND ND NDND NDND
Ce StCo HiHy Am Ce StCo HiHy Am
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